drugset / Trial / NCT06777758

Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments

NCT06777758

Phase 4 Recruiting 90 enrolled Kaohsiung Veterans General Hospital.
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.

Timeline

Start
2025-02-12
Primary completion
2026-12-31
Completion
2026-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule
Subject Remimazolam Small molecule